Immunopathology of Hyperinflammation in COVID-19

por Gustine, Joshua N., Jones, Dennis
Publicado 2021

Light chain amyloidosis associated with Waldenström macroglobulinemia: treatment and survival outcomes

por Gustine, Joshua N., Szalat, Raphael E., Staron, Andrew, Joshi, Tracy, Mendelson, Lisa, Sloan, J. Mark, Sanchorawala, Vaishali
Publicado 2022

Predictors of treatment response and survival outcomes in patients with advanced cardiac AL amyloidosis

por Gustine, Joshua N., Staron, Andrew, Mendelson, Lisa, Joshi, Tracy, Gopal, Deepa M., Siddiqi, Omar K., Ruberg, Frederick L., Sanchorawala, Vaishali
Publicado 2023

1130. Low Risk of Pneumocystis jiroveci Pneumonia in Patients With Waldenstrom’s Macroglobulinemia on Ibrutinib

por Kusztos, Amanda E, Cheng, Matthew P, Gustine, Joshua N, Dubeau, Toni E, Woolley, Ann E, Hammond, Sarah P, Baden, Lindsey R, Castillo, Jorge J, Issa, Nicolas C
Publicado 2018

Response and Survival Outcomes to Ibrutinib Monotherapy for Patients With Waldenström Macroglobulinemia on and off Clinical Trials

por Castillo, Jorge J., Gustine, Joshua N., Meid, Kirsten, Flynn, Catherine A., Demos, Maria G., Guerrera, Maria L., Jimenez, Cristina, Kofides, Amanda, Liu, Xia, Munshi, Manit, Tsakmaklis, Nicholas, Patterson, Christopher J., Xu, Lian, Yang, Guang, Hunter, Zachary R., Treon, Steven P.
Publicado 2020

Response and survival predictors in a cohort of 319 patients with Waldenström macroglobulinemia treated with ibrutinib monotherapy

por Castillo, Jorge J., Sarosiek, Shayna R., Gustine, Joshua N., Flynn, Catherine A., Leventoff, Carly R., White, Timothy P., Meid, Kirsten, Guerrera, Maria L., Kofides, Amanda, Liu, Xia, Munshi, Manit, Tsakmaklis, Nicholas, Hunter, Zachary R., Patterson, Christopher J., Branagan, Andrew R., Treon, Steven P.
Publicado 2022

Natural history of Waldenström macroglobulinemia following acquired resistance to ibrutinib monotherapy

por Gustine, Joshua N., Sarosiek, Shayna, Flynn, Catherine A., Meid, Kirsten, Leventoff, Carly, White, Timothy, Guerrera, Maria Luisa, Xu, Lian, Kofides, Amanda, Tsakmaklis, Nicholas, Munshi, Manit, Demos, Maria, Patterson, Christopher J., Liu, Xia, Yang, Guang, Hunter, Zachary R., Branagan, Andrew R., Treon, Steven P., Castillo, Jorge J.
Publicado 2021

Diagnostic Next-generation Sequencing Frequently Fails to Detect MYD88(L265P) in Waldenström Macroglobulinemia

por Kofides, Amanda, Hunter, Zachary R., Xu, Lian, Tsakmaklis, Nicholas, Demos, Maria G., Munshi, Manit, Liu, Xia, Guerrera, Maria Luisa, Leventoff, Carly R., White, Timothy P., Flynn, Catherine A., Meid, Kirsten, Patterson, Christopher J., Yang, Guang, Branagan, Andrew R., Sarosiek, Shayna, Castillo, Jorge J., Treon, Steven P., Gustine, Joshua N.
Publicado 2021

Long-term follow-up of ibrutinib monotherapy in treatment-naive patients with Waldenstrom macroglobulinemia

por Castillo, Jorge J., Meid, Kirsten, Gustine, Joshua N., Leventoff, Carly, White, Timothy, Flynn, Catherine A., Sarosiek, Shayna, Demos, Maria G., Guerrera, Maria L., Kofides, Amanda, Liu, Xia, Munshi, Manit, Tsakmaklis, Nicholas, Xu, Lian, Yang, Guang, Branagan, Andrew R., O’Donnell, Elizabeth, Raje, Noopur, Yee, Andrew J., Patterson, Christopher J., Hunter, Zachary R., Treon, Steven P.
Publicado 2021